Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01466946|
Recruitment Status : Completed
First Posted : November 8, 2011
Last Update Posted : February 11, 2016
|Condition or disease||Intervention/treatment|
|Lung Cancer||Behavioral: semi-structured interviews|
|Study Type :||Observational|
|Actual Enrollment :||25 participants|
|Official Title:||Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients|
|Study Start Date :||November 2011|
|Actual Primary Completion Date :||February 2016|
|Actual Study Completion Date :||February 2016|
A qualitative study of MSKCC lung cancer patients of Hispanic/Latino descent by collecting retrospective patient narratives to understand the processes that led them to seek medical help when they did, their experiences in seeking and receiving medical guidance, as well as their decisions regarding lung cancer treatment. In addition, we will explore how these patients' representations of lung cancer with its associated risk factors and symptoms affected their treatment decisions.
Behavioral: semi-structured interviews
Use semi-structured interview methods to gather narrative data from research participants, as more open-ended interviews allow participants to share information that is most relevant to their own experiences (Patton, 2002; Rubin & Rubin, 2005; Kvale, 1996). Semi-structured interviewing can generate a rich understanding of a participant's life routines, experiences, and attitudes related to a topic of inquiry, and can yield a nuanced and thorough description of a research participant's life story and belief systems.
- psychosocial issues [ Time Frame: 2 years ]related to lung cancer symptom recognition, delays in lung cancer diagnosis of Hispanic/Latino patients and treatment decision-making processes.
- cultural issues [ Time Frame: 2 years ]related to lung cancer symptom recognition, delays in lung cancer diagnosis of Hispanic/Latino patients and treatment decision-making processes.
- identify obstacles [ Time Frame: 2 years ]that have been overcome by Hispanic/Latino lung cancer patients who have succeeded in obtaining access to care at an NCI-designated cancer center, and probe for barriers that these individuals believe still need to be addressed or that they were not successful in surpassing.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01466946
|United States, New York|
|Memorial Sloan Kettering Cancer Center|
|New York, New York, United States, 10065|
|Principal Investigator:||William Alago, MD||Memorial Sloan Kettering Cancer Center|